Ecopetrol (EC) Stock Declines While Market Improves: Some Information for Investors
In the most recent trading session, Ecopetrol (EC) closed at $16.96, indicating a -1.68% shift from the previous trading day.
EC - Ecopetrol S.A.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$16.85
DETAILS
HIGH:
$17.70
LOW:
$16.00
MEDIAN:
$16.85
CONSENSUS:
$16.85
DOWNSIDE:
4.10%
Stock News
Ecopetrol S.A. (EC) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Ecopetrol (EC). This makes it worthwhile to examine what the stock has in store.
New Strong Buy Stocks for October 5th
EC, CBRL, GCT, DG and NWL have been added to the Zacks Rank #1 (Strong Buy) List on October 5th, 2026.
Best Value Stocks to Buy for October 5th
NWL, EC and GCT made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 5th, 2026.
Best Income Stocks to Buy for October 5th
NWL, EC, DG made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 5th, 2026.
Ecopetrol Announces Changes to Senior Management
BOGOTÁ, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the "Company") announced today that Cristina Toro Restrepo, Corporate Vice President of Legal Affairs and General Secretary, will continue to serve in that position through September 30, 2026, following the termination of her employment relationship by decision of the Company, effective as of that date.
Ecopetrol Advances Its Transformation with Changes to Its Senior Management Team
BOGOTÁ, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the "Company" or "Ecopetrol") announced today that its Board of Directors, at a meeting held on September 30, 2026, approved the appointment of three new members of senior management, as part of the Company's ongoing strategy to strengthen key capabilities for its next phase of development.
Ecopetrol Group, in coordination with the National Government, receives payment of the Fuel Price Stabilization Fund (FEPC, by its Spanish acronym) receivable corresponding to the third and fourth quarters of 2025
BOGOTÁ, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the "Company") hereby announces that, pursuant to coordinated efforts undertaken with the National Government of Colombia, acting through the Ministry of Finance and Public Credit (Ministerio de Hacienda y Crédito Público) and the Ministry of Mines and Energy (Ministerio de Minas y Energía), it has received payment of the outstanding receivable owed by the Fuel Price Stabilization Fund (Fondo de Estabilización de Precios de los Combustibles, "FEPC") corresponding to the third and fourth quarters of 2025.
Ecopetrol S.A. (NYSE:EC) Receives Average Recommendation of “Reduce” from Brokerages
Ecopetrol S.A. (NYSE: EC - Get Free Report) has been assigned an average rating of "Reduce" from the eight analysts that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating and seven have issued a hold rating on the company. The average twelve-month price objective among brokerages that have
Ecopetrol (EC) Suffers a Larger Drop Than the General Market: Key Insights
Ecopetrol (EC) reached $16.52 at the closing of the latest trading day, reflecting a -1.08% change compared to its last close.
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
NANJING, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company's proprietary PD‑L1/4‑1BB bispecific antibody, has been granted Orphan Drug Designation (ODD) by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of extrapulmonary neuroendocrine carcinoma (EP-NEC). This is the third Orphan Drug Designation for opamtistomig, following designations in the U.S. Food and Drug Administration (FDA) and the European Commission (EC), marking a further expansion of its global regulatory recognition into a strategically important Asian market.
66,837 Ecopetrol S.A. $EC Shares Sold by Squarepoint Ops LLC
Squarepoint Ops LLC lessened its stake in shares of Ecopetrol S.A. (NYSE: EC) by 83.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,890 shares of the oil and gas company's stock after selling 66,837 shares during the quarter. Squarepoint
Ecopetrol's Board of Directors Unanimously Appoints Joaquín Gutiérrez Caballero as the Company's New Chief Executive Officer
BOGOTÁ, Colombia, Sept. 24, 2026 /PRNewswire/ -- Ecopetrol S.A.
Colombia state oil firm Ecopetrol names Joaquin Gutierrez as CEO, Blu Radio reports
Colombian state oil firm Ecopetrol has appointed Joaquin Gutierrez as its chief executive, a long awaited decision by markets, Blu Radio reported on Thursday.
Here's Why Ecopetrol (EC) Fell More Than Broader Market
Ecopetrol (EC) closed at $16.69 in the latest trading session, marking a -1.3% move from the prior day.
The Law Offices of Frank R. Cruz Continues Its Investigation of Ecopetrol S.A.
LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--The Law Offices of Frank R. Cruz Continues Its Investigation of Ecopetrol S.A. (EC) on Behalf of Investors.
Investors Heavily Search Ecopetrol S.A. (EC): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Ecopetrol (EC). This makes it worthwhile to examine what the stock has in store.
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
AbbVie Announces European Commission Approval of RINVOQÂ (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic ArthritisPR
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency's Committee for Medicinal Products for Hu
Colombia state oil firm Ecopetrol taps De La Espriella ally as chair, El Tiempo reports
Colombian state oil firm Ecopetrol has tapped Carlos Augusto Suarez, who worked on President Abelardo De La Espriella's campaign, as chairman of the board, newspaper El Tiempo reported on Thursday.
Price Targets
Ecopetrol price target raised to $17.70 from $15.40 at Goldman Sachs
$17.70
(was $16.96)
Goldman Sachs
Ecopetrol price target raised to $16 from $14 at UBS
$16.00
(was $17.55)
UBS
Ecopetrol price target raised to $14 from $13.50 at UBS
$14.00
(was $14.74)
UBS
Ecopetrol price target raised to $13.50 from $10 at UBS
$13.50
(was $13.85)
UBS
Ecopetrol downgraded to Underperform from Outperform at Bradesco BBI
$12.00
(was $11.87)
Bradesco
Ecopetrol price target raised to $8.70 from $7.10 at Goldman Sachs
$8.70
(was $9.82)
Goldman Sachs
Ecopetrol SA (EC) PT Lowered to $6.80 at Jefferies
$6.80
(was $8.03)
Alejandro Demichelis
·
Jefferies
Ecopetrol downgraded to Underperform from Neutral at Grupo Santander
$10.20
(was $10.09)
Rodrigo Reis de Almeida
·
Banco Santander
Ecopetrol downgraded to Neutral from Buy at BTG Pactual
$12.50
(was $11.74)
Daniel Guardiola
·
BTG Pactual